US 12,421,209 B2
Compounds
Lea Aurelie Bouche, Basel (CH); Wolfgang Guba, Müllheim (DE); Georg Jaeschke, Basel (CH); Stefanie Katharina Mesch, Basel (CH); Angelique Patiny-Adam, Kembs (FR); Christian Schnider, Biel-Benken (CH); Sandra Steiner, Sursee (CH); and Andreas Michael Tosstorff, Basel (CH)
Assigned to Hoffmann-La Roche Inc., Little Falls, NJ (US)
Filed by Hoffmann-La Roche Inc., Little Falls, NJ (US)
Filed on Feb. 25, 2025, as Appl. No. 19/063,141.
Application 19/063,141 is a continuation of application No. 18/524,678, filed on Nov. 30, 2023.
Application 18/524,678 is a continuation of application No. PCT/EP2022/064995, filed on Jun. 2, 2022.
Claims priority of application No. 21177660 (EP), filed on Jun. 4, 2021; application No. 21188639 (EP), filed on Jul. 30, 2021; and application No. 21215875 (EP), filed on Dec. 20, 2021.
Prior Publication US 2025/0197370 A1, Jun. 19, 2025
Int. Cl. C07D 401/12 (2006.01); C07D 253/07 (2006.01); C07D 405/14 (2006.01); C07D 471/04 (2006.01)
CPC C07D 401/12 (2013.01) [C07D 253/07 (2013.01); C07D 405/14 (2013.01); C07D 471/04 (2013.01)] 2 Claims
 
1. A compound represented by:

OG Complex Work Unit Chemistry
or a pharmaceutically acceptable salt thereof.